Ignite Creation Date:
2024-05-06 @ 5:32 PM
Last Modification Date:
2024-10-26 @ 2:31 PM
Study NCT ID:
NCT05348304
Status:
COMPLETED
Last Update Posted:
2022-10-13
First Post:
2022-04-21
Brief Title:
Hypoglycemic Effects of a Dietary Supplement With Inositols Gymnema Silvestre Alpha-lactalbumin and Zinc
Sponsor:
LoLiPharma srl
Organization:
LoLiPharma srl
Study Overview
Official Title:
Hypoglycemic Effects of a Dietary Supplement That Combines the Properties of Myo-inositol and D-chiro-inositol With Gymnema Silvestre Alpha-lactalbumin and Zinc
Status:
COMPLETED
Status Verified Date:
2022-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
EUDIA_22
Brief Summary:
This study is aimed at evaluating the hypoglycemic effects of a dietary supplement that associates the properties of two inositols myo-inositol and D-chiro-inositol in the ratio 401 to Gymnema sylvestre alpha-lactalbumin and zinc
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None